The global oncology diagnostics industry is undergoing rapid transformation, with the Cancer Biopsies Market becoming a crucial component in early cancer detection and personalized treatment planning. The increasing prevalence of multiple cancer types, advancements in minimally invasive diagnostic technologies, and rising awareness regarding early diagnosis are significantly contributing to...

The global healthcare industry is witnessing remarkable growth in oncology diagnostics, with the Cancer Tissue Diagnostics Market playing a crucial role in early cancer detection and personalized treatment planning. Tissue diagnostics technologies are increasingly being adopted across hospitals, diagnostic laboratories, and research institutions to improve cancer diagnosis accuracy and support...

According to a new report from Intel Market Research, the global Digital Therapeutics Devices market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 35.78 billion by 2034, exhibiting a robust CAGR of 21.0% during the forecast period (2026–2034). This rapid expansion is underpinned by escalating prevalence of chronic illnesses, soaring...

According to a new report from Intel Market Research, the global Microfluidic Semiconductor market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.04 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This expansion is driven by accelerating investment in personalized medicine, cost‑effective CMOS fabrication advances, and...

According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...

The metabolism drugs market is witnessing significant expansion as healthcare systems worldwide focus on addressing the growing burden of metabolic disorders. These medications play a crucial role in managing conditions associated with abnormal metabolic processes, including inherited metabolic diseases, enzyme deficiencies, and various chronic disorders that affect the body's ability to...

The United States represents a major contributor to the smart drug delivery system market, driven by advanced healthcare infrastructure, high adoption of connected medical devices, and the growing prevalence of chronic diseases such as diabetes and cardiovascular disorders. Increasing investments in digital health technologies and strong focus on patient-centered care continue to support the...